Navigation Links
Consumer Group Urges Gov. Schwarzenegger to Sign Stem Cell Bill Into Law
Date:9/15/2008

SANTA MONICA, Calif., Sept. 15 /PRNewswire-USNewswire/ -- Gov. Arnold Schwarzenegger should sign a stem cell public accountability bill, SB1565, into law, Consumer Watchdog said today. The bill, sponsored by Sen. Sheila Kuehl and Sen. George Runner, was passed with overwhelming bipartisan support in both houses of the Legislature.

In a letter to the governor, the nonpartisan, nonprofit consumer advocacy organization said the bill would help ensure that the people paying $6 billion for stem cell research -- the taxpayers of California -- will have affordable access to the fruits of the research they are funding. In addition the bill will help make the California Institute of Regenerative Medicine (CIRM) and the Independent Citizens Oversight Committee (ICOC) more responsive and accountable to the public. It asks the state's Little Hoover Commission to recommend ways to ensure public accountability and reduce conflicts of interest on the ICOC.

"The bill simply codifies into law the intellectual property provisions worked out through the agency's regulatory process," said John M. Simpson, Consumer Watchdog Stem Cell project director. "Without this law the relatively modest provisions are likely to be changed in the face of corporate pressure. And certainly an unbiased examination by the Little Hoover Commissioners can only benefit the $6 billion program."

Consumer Watchdog will continue to seek legislation that would give the attorney general the right to intervene if drugs or treatments funded by CIRM are priced unreasonably.

"This is actually a very modest bill in its scope," said Simpson. "One important thing it does is demonstrate that the Legislature has an appropriate oversight role regarding the stem cell agency. It is, after all, a state agency -- not a private foundation."

Read consumer Watchdog's letter to the governor at http://www.consumerwatchdog.org/resources/CWDSB1565Govlet.pdf.

Consumer Watchdog's Stem Cell Oversight and Accountability Project is working to ensure that California's landmark stem cell research program offers accessible and affordable cures and treatments to the taxpayers who have funded it. The program will sell $3 billion in bonds over a decade to fund stem cell research. Financing charges mean the project, the largest source of stem cell research funding in the world, will cost California taxpayers $6 billion.

Consumer Watchdog is California's leading nonprofit and nonpartisan consumer watchdog group. For more information visit us on the web at: http://www.ConsumerWatchdog.org.


'/>"/>
SOURCE Consumer Watchdog
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Lebanon County Dairy
2. Florastor(R) Receives ConsumerLab.com Certification
3. Survey Finds At-Risk Consumers Interested in OTC Statin
4. Dog Law Officers Crackdown on Unsatisfactory Kennels Protecting Animals, Consumers
5. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Chester County Dairy
6. Consumer Advocates Support Patent Office on Stem Cell Patent Rejection
7. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
8. Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida
9. Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials
10. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
11. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017 MabVax ... oncology drug development company, announces that it has ... Administration (FDA) authorizing the initiation a Phase I ... for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is ... MabVax plans to initiate the phase I clinical ...
(Date:2/23/2017)... 23, 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) ... oncology and dermatology biopharmaceutical company, today announced that it ... Rodrigues as special advisers to the Company,s Board ... the board on financial and corporate strategy. ... commitment of up to $2.5 million from Eric ...
(Date:2/23/2017)... Feb. 22, 2017 Medical Imaging ... imaging is performed to reveal the internal structures hidden ... the medical condition. It plays a vital role not ... as it is taken into consideration during the follow-up ... X-rays, SPECT/PET, ultrasound, CT, and MRI. For the diagnosis ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... Current Meditation , a ... franchising throughout the U.S. starting this spring. Current Meditation focuses on “meditation for ... mainstream. Current Meditation will be the first meditation concept in the U.S. offering ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Center for Autism and ... for Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. ... to see films in an environment that accommodates their unique needs. , Launched ...
(Date:2/23/2017)... ... February 23, 2017 , ... CALNOC, the nation’s first and only nursing ... upcoming conference – Empowerment, Value and Collaboration – in Seattle, WA on October 23, ... Virginia Mason Health System in Seattle since 2000. In addition to his role at ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/23/2017)... Australia (PRWEB) , ... February 23, 2017 , ... ... With perseverance and disciplined exercise regime, the author was able to successfully recover. In ... collates all relevant information for various sources on the principals of massage, anatomy ...
Breaking Medicine News(10 mins):